These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 10699292

  • 1. The effect of egg albumin on the crystalline properties of carbamazepine in sustained release hydrophilic matrix tablets and in aqueous solutions.
    Katzhendler I, Azoury R, Friedman M.
    J Control Release; 2000 Apr 03; 65(3):331-43. PubMed ID: 10699292
    [Abstract] [Full Text] [Related]

  • 2. Crystalline properties of carbamazepine in sustained release hydrophilic matrix tablets based on hydroxypropyl methylcellulose.
    Katzhendler I, Azoury R, Friedman M.
    J Control Release; 1998 Jun 03; 54(1):69-85. PubMed ID: 9741905
    [Abstract] [Full Text] [Related]

  • 3. Investigating the structure and properties of hydrated hydroxypropyl methylcellulose and egg albumin matrices containing carbamazepine: EPR and NMR study.
    Katzhendler I, Mäder K, Azoury R, Friedman M.
    Pharm Res; 2000 Oct 03; 17(10):1299-308. PubMed ID: 11145238
    [Abstract] [Full Text] [Related]

  • 4. Investigation of the effect of hydroxypropyl methylcellulose on the phase transformation and release profiles of carbamazepine-nicotinamide cocrystal.
    Li M, Qiu S, Lu Y, Wang K, Lai X, Rehan M.
    Pharm Res; 2014 Sep 03; 31(9):2312-25. PubMed ID: 24590881
    [Abstract] [Full Text] [Related]

  • 5. Variability in commercial carbamazepine samples--impact on drug release.
    Flicker F, Eberle VA, Betz G.
    Int J Pharm; 2011 May 30; 410(1-2):99-106. PubMed ID: 21435386
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Surfactant-facilitated crystallization of dihydrate carbamazepine during dissolution of anhydrous polymorph.
    Rodríguez-Hornedo N, Murphy D.
    J Pharm Sci; 2004 Feb 30; 93(2):449-60. PubMed ID: 14705201
    [Abstract] [Full Text] [Related]

  • 14. Controlled-release carbamazepine granules and tablets comprising lipophilic and hydrophilic matrix components.
    Barakat NS, Elbagory IM, Almurshedi AS.
    AAPS PharmSciTech; 2008 Feb 30; 9(4):1054-62. PubMed ID: 18843537
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Adsorption onto Mesoporous Silica Using Supercritical Fluid Technology Improves Dissolution Rate of Carbamazepine-a Poorly Soluble Compound.
    Gandhi AV, Thipsay P, Kirthivasan B, Squillante E.
    AAPS PharmSciTech; 2017 Nov 30; 18(8):3140-3150. PubMed ID: 28534299
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.